[HTML][HTML] Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in …

P Godoy, NJ Hewitt, U Albrecht, ME Andersen… - Archives of …, 2013 - Springer
This review encompasses the most important advances in liver functions and hepatotoxicity
and analyzes which mechanisms can be studied in vitro. In a complex architecture of nested …

Pharmacogenomics of drug metabolizing enzymes and transporters: relevance to precision medicine

S Ahmed, Z Zhou, J Zhou… - Genomics, proteomics and …, 2016 - academic.oup.com
The interindividual genetic variations in drug metabolizing enzymes and transporters
influence the efficacy and toxicity of numerous drugs. As a fundamental element in precision …

[HTML][HTML] Bile acid transporters and regulatory nuclear receptors in the liver and beyond

E Halilbasic, T Claudel, M Trauner - Journal of hepatology, 2013 - Elsevier
Bile acid (BA) transporters are critical for maintenance of the enterohepatic BA circulation
where BAs exert their multiple physiological functions including stimulation of bile flow …

Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature

S Wolking, E Schaeffeler, H Lerche, M Schwab… - Clinical …, 2015 - Springer
ATP-binding cassette transporter B1 (ABCB1; P-glycoprotein; multidrug resistance protein 1)
is an adenosine triphosphate (ATP)-dependent efflux transporter located in the plasma …

Emerging transporters of clinical importance: an update from the International Transporter Consortium

KM Hillgren, D Keppler, AA Zur… - Clinical …, 2013 - Wiley Online Library
The International Transporter Consortium (ITC) has recently described seven transporters of
particular relevance to drug development. Based on the second ITC transporter workshop in …

Simultaneous absolute protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases as a novel approach for the characterization of …

S Ohtsuki, O Schaefer, H Kawakami, T Inoue… - Drug metabolism and …, 2012 - ASPET
The purpose of the present study was to determine the absolute protein expression levels of
multiple drug-metabolizing enzymes and transporters in 17 human liver biopsies, and to …

[PDF][PDF] Drug‐induced cholestasis

MS Padda, M Sanchez, AJ Akhtar, JL Boyer - Hepatology, 2011 - Wiley Online Library
Recent progress in understanding the molecular mechanisms of bile formation and
cholestasis have led to new insights into the pathogenesis of drug‐induced cholestasis. This …

Risk factors for idiosyncratic drug-induced liver injury

N Chalasani, E Björnsson - Gastroenterology, 2010 - Elsevier
Idiosyncratic drug-induced liver injury (DILI) is a rare disorder that is not related directly to
dosage and little is known about individuals who are at increased risk. There are no suitable …

[HTML][HTML] Sorafenib resistance in hepatocellular carcinoma: the relevance of genetic heterogeneity

LKD Cabral, C Tiribelli, CHC Sukowati - Cancers, 2020 - mdpi.com
Despite advances in biomedicine, the incidence and the mortality of hepatocellular
carcinoma (HCC) remain high. The majority of HCC cases are diagnosed in later stages …

The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation

B Stieger - Drug transporters, 2011 - Springer
Bile formation is an important function of the liver. Bile salts are a major constituent of bile
and are secreted by hepatocytes into bile and delivered into the small intestine, where they …